RecruitingNot ApplicableNCT05360290

CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial

The Value of Circulating Tumor Cells in Patients With Breast Cancer Who Completed Surgery After Neoadjuvant Treatment: a Multicenter, Prospective Clinical Trial


Sponsor

RenJi Hospital

Enrollment

484 participants

Start Date

Sep 14, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The GILUPI CellCollector® is the first in vivo CTC isolation product worldwide, which is CE approved. This is a prospective, multicenter study to evaluate the prognostic value of circulating tumor cells in breast cancer patients who completed surgery after neoadjuvant treatment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking circulating tumor cells (cancer cells that travel through the bloodstream) in women with breast cancer who have already completed chemotherapy and surgery, to understand whether these cells can predict cancer recurrence. **You may be eligible if...** - You are a woman between 18 and 70 years old - You have been diagnosed with invasive breast cancer at a specific stage - You completed chemotherapy before surgery (neoadjuvant chemotherapy) and have since had surgery (within the last 4 years) - Your general health score (ECOG) is 0 or 1 **You may NOT be eligible if...** - Your cancer has spread to distant organs (stage IV) - You are currently pregnant or breastfeeding - You have an uncontrolled infection at the puncture site or throughout your body Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGILUPI CellCollector®

Use of GILUPI CellCollector® to detect CTC


Locations(1)

Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05360290


Related Trials